Collect. Czech. Chem. Commun.
1969, 34, 479-484
https://doi.org/10.1135/cccc19690479
Synthetic sympatholytics. III. Some 3-aryl-2-hydroxypropylamines and 4-aryl-2-hydroxybutylamines
E. Adlerová, V. Trčka, V. Šmejkal and M. Protiva
Crossref Cited-by Linking
- Washburn W.N., Harper T.W., Wu G., Godfrey J.D., McCann P., Girotra R., Shao C., Zhang H., Gavai A., Mikkilineni A., Dejneka T., Ahmed S., Caringal Y., Hangeland J., Zhang M., Cheng P.T.W., Russell A.D., Skwish S., Slusarchyk D.A., Allen G.T., Frohlich B.H., Abboa-Offei B.E., Cap M., Waldron T.L., George R.J., Tesfamariam B., Dickinson K.E., Seymour A.A., Sher P.M.: Arylpropanolamines: Selective β3 agonists arising from strategies to mitigate phase I metabolic transformations. Bioorganic & Medicinal Chemistry Letters 2007, 17, 4290. <https://doi.org/10.1016/j.bmcl.2007.05.030>
- Nudelman Abraham, Binnes Yitschak, Shmueli‐Broide Naomi, Odessa Yael, Hieble J. Paul, Sulpizio Anthony C.: “Vinylogs” and “Acetylenylogs” of β‐Adrenergic Agents. Archiv der Pharmazie 1996, 329, 125. <https://doi.org/10.1002/ardp.19963290304>
- Peč Pavel, Frébort Ivo: Comparison of Coupling Subsites and Inhibition Effects of Piperidine Alkaloids and Aminoketones on Plant Amine Oxidases. Journal of Enzyme Inhibition 1991, 4, 327. <https://doi.org/10.3109/14756369109030397>
